维普期刊资源整合服务平台（V6.5）

426篇 您的检索式：作者名="Sequist"

选中清除导出查看参考文献查看引证文献引用追踪共22页首页上一页第1页下一页末页 /22 跳转

	题名	作者	年代	出处	被引量
1	Detection of mutations in EGFR in circulating lung-cancer cells显示文摘	Maheswaran S Sequist LV Nagrath S	2008	NEngl JMed2008，359，4：	1
2	Molecular predictors of response to epidermal growth factor receptor antagonists in non - small-cell lung cancer 显示文摘	Sequist LV Bell DW Lynch TJ	2007	J Clin Oncol2007，25，5：	1
3	Clinical activity of afa-inib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2' LUX-Lung 3, and LUX-Lung 6显示文摘	Yang CH Sequist LV Geater SL	2015	Lan cet 0ncol2015，16，7：	1
4	Isolation of rare circulating tumour cells in cancer patients by microchip technology 显示文摘	Nagrath S Sequist LV Maheswaran S	2007	Nature2007，450，7173：	1
5	Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer显示文摘	Sequist LV Bell DW Lynch TJ	2007	J Clin Oncol2007，25，：	1
6	Molecular predictors of response to epidermal growth factor receptor antagonists in non- small-cell lung cancer 显示文摘	Sequist LV Bell DW Lynch TJ Haber DA	2007	J Clin Oncol2007，25，5：	1
7	Detection of mutations in EGFR in circulating lung-cancer cells显示文摘	Maheswaran S Sequist LV Nagrath S	2008	N Engl J Med2008，359，4：	1
8	Genotypic and histological evolution lung cancers acquiring resistance to EGFR inhibitors显示文摘	SEQUIST L V WALTMAN B A DIAS-SANTAGATA D	2011	Sci Transl Med2011，3，75：	1
9	Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors显示文摘	Sequist LV Waltman BA Dias-Santagata D	2011	Sci Transl Med2011，3，75：	1
10	Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors显示文摘	Sequist LV Waltman BA Dias-Santagata D		0，，75：	1
11	Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors显示文摘	Sequist LV Waltman BA Dias-Santagata D		0，，75：	1
12	Rociletinib in EGFR- mutated non-small-cell lung cancer 显示文摘	Sequist LV Sofia JC Goldman JW	2015	N Engl J Med2015，372，18：	1
13	EGFR Tyrosine Kinase Inhibitors in Lung Cancer: An Evolving Story显示文摘	Sequist L V Lynch T J	2008	Annu Rev Med2008，59，：	1
14	Isolation of rare circulating tumour cells in cancer patients by microchip technology显示文摘	Nagrath S Sequist LV Maheswaran S	2007	Nature2007，450，7173：	1
15	First-in-hunmn evaluation of CO-1686, an irreversible, highly selective tyrosine kinase inhibitor of mutations of EGFR (activating and T790M ) 显示文摘	Sequist L Soria JC Gadgeel SM	2014	J Clin Oncol2014，32，5：	1
16	Detection of mu talions in EGFR in circulating lung cancer eells显示文摘	Maheswaran S Sequist LV Nagrath S	2008	N Engl J Med2008，359，4：	1
17	First-line use of EGFR tyrosine kinase inhibitors in patients with NSCLC containing EGFR mutations显示文摘	Neal JW Sequist LV	2010	Clin Adv He- matol Oncol2010，8，2：	1
18	Rociletinib in EGFR-mutated non-small-cell lung cancer 显示文摘	Sequist LV Soria JC Goldman JW	2015	N Engl J Med2015，372，18：	1
19	Geno- typic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors显示文摘	Sequist LV Waltman BA Dias-Santagata D	2011	Sci Transl Med2011，3，75：	1
20	Detection of mutations in EGFR in circulating lung-cancer cells显示文摘	Maheswaran S Sequist LV Nagrath S	2008	N Engl J Med2008，359，4：	1

返回顶部每页显示：

共22页首页上一页第1页下一页末页 /22 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示